Research ArticleCardiovascular
A Novel Orally Available Delta-5 Desaturase Inhibitor Prevents Atherosclerotic Lesions Accompanied by Changes in Fatty Acid Composition and Eicosanoid Production in ApoE Knockout Mice
Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
Journal of Pharmacology and Experimental Therapeutics November 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
Shuichi Takagahara
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Hiromi Shinohara
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Shigekazu Itokawa
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Yoshinori Satomi
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Ayumi Ando
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Takeshi Yamamoto
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Hideo Suzuki
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Takuya Fujimoto
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Kazuki Kubo
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Shota Ikeda
Cardiovascular and Metabolic Drug Discovery Unit (S.T., H.Sh, S.I., T.Y., H.Su, T.F., K.K., S.I.) and Integrated Technology Research Laboratories (Y.S., A.A.), Takeda Pharmaceutical Company Limited, Kanagawa, Japan
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
D5D Inhibitor Prevents Atherosclerosis in ApoE KO Mice
Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
Journal of Pharmacology and Experimental Therapeutics November 1, 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
Research ArticleCardiovascular
D5D Inhibitor Prevents Atherosclerosis in ApoE KO Mice
Shuichi Takagahara, Hiromi Shinohara, Shigekazu Itokawa, Yoshinori Satomi, Ayumi Ando, Takeshi Yamamoto, Hideo Suzuki, Takuya Fujimoto, Kazuki Kubo and Shota Ikeda
Journal of Pharmacology and Experimental Therapeutics November 1, 2019, 371 (2) 290-298; DOI: https://doi.org/10.1124/jpet.119.259846
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement